Blog - Page 3 of 5737 - QualityStocks

TuesdaySep 15, 2026 11:44 am

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Appoints Rauni Malhi to Board of Directors

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced the appointment of Rauni Malhi as a director effective Sept. 15, 2026, following the resignation of Michael Kelly effective Sept. 7. Malhi, a British Columbia-based paralegal, has served on the boards of several TSX Venture Exchange-listed issuers, including Cairo Resources, which was rebranded as Gladiator Metals Corp. (TSXV: GLAD). LaFleur also granted Malhi 500,000 incentive stock options exercisable at $0.40 per share through Sept. 15, 2031, with half vesting immediately and the remainder vesting six months from the grant date. To view the full press…

TuesdaySep 15, 2026 11:36 am

QualityStocksNewsBreaks – BOXABL Inc. (NASDAQ: BXBL) Strengthens Finance Leadership With CFO, Chief Accounting Officer Appointments

BOXABL (NASDAQ: BXBL), a leader in innovative, factory-built modular solutions, announced the appointment of Larry King, CPA, as chief financial officer and Heather Clayton as chief accounting officer, strengthening its finance leadership as it builds out the infrastructure of a newly public company. King brings more than 35 years of finance, accounting and operations experience, including extensive SEC reporting, mergers and acquisitions and operational turnaround work, with prior senior roles at Chukchansi Gold Resort & Casino, Riviera Holdings Corp. and Tropicana Entertainment. Clayton brings nearly a decade of experience building and scaling finance and accounting functions for fast-growing, multi-entity organizations, including six years with the Vegas Golden…

TuesdaySep 15, 2026 10:30 am

Market Street Capital Inc. Sees Rising Power Demand Driving New Capital Choices for Founders

Energy is one of the sectors where the debt vs. equity decision has become especially pressing. As Market Street frames it, the tradeoff is straightforward in concept but consequential in practice. This is the kind of decision Market Street Capital's platform is built to help energy founders work through. For a growing number of middle-market energy founders, the hardest strategic decision is not what to build next but how to pay for it. Market Street Capital, a capital markets and financial advisory firm, works with established middle-market businesses navigating exactly this kind of decision. The company’s team members have spent…

TuesdaySep 15, 2026 9:45 am

BOXABL Inc. (NASDAQ: BXBL) Joins Nasdaq Following SPAC Merger Approval, Bringing Factory-Built Housing Model to Public Markets

PAID ADVERTISEMENT. This article is a paid advertisement for BOXABL Inc. (Nasdaq: BXBL), distributed by NetworkNewsWire (“NNW”), a division of InvestorBrandNetwork (“IBN”). IBN has been compensated for advertising and digital media services related to BOXABL Inc. Readers should review the full disclaimer at the foot of this article before making any investment decision. BOXABL has begun trading on Nasdaq under the ticker symbol BXBL. The move values BOXABL at approximately $3.5 billion, with approximately 350 million shares issued at $10 per share. The company has so far raised over $230 million from 50,000+ investors. BOXABL is pursuing a technology-driven approach…

TuesdaySep 15, 2026 9:45 am

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Reports Best Natural Hydrogen Readings to Date at Lawson Discovery

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) provided an exploration and operational update from its Lawson Natural Hydrogen Discovery in south-central Saskatchewan, reporting its highest Natural Hydrogen readings to date. Lawson 4 intersected a highly prospective 20.5-metre interval with evidence of strong permeability and porosity in the basal Cambrian Sandstone immediately above the Precambrian basement complex and a deep crustal fault. The company recovered 51.4 metres of core across the sandstone and underlying basement, with very elevated Natural Hydrogen readings and favorable…

TuesdaySep 15, 2026 9:10 am

QualityStocksNewsBreaks – Lahontan Gold Corp. (TSXV: LG) (OTCQB: LGCXF) Reports Encouraging Gold, Silver Results From Santa Fe Heap Leach Pad

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising. Lahontan Gold (TSXV: LG) (OTCQB: LGCXF) announced additional results from its 2026 Sonic core drilling program at the Santa Fe Mine Project in Nevada, reporting 10 holes totaling 168.9 metres from historic Heap Leach Pad Two, with nearly every 0.76-metre drill interval containing meaningful gold and silver mineralization. Based on the first 10 of 26 completed holes at HLP Two, all samples returned a weighted average grade of 0.50 g/t gold and 3.3 g/t silver, or 0.54 g/t gold equivalent, compared with an estimated…

TuesdaySep 15, 2026 9:00 am

VERAXA Biotech AG (NASDAQ: VRXA) Building a New Approach to Precision Cancer Therapy

VERAXA is developing antibody-based cancer therapies aimed at improving the therapeutic window of existing treatment modalities. Its proprietary BiTAC platform uses two complementary molecules that are designed to activate cytotoxic activity only when both recognize targets on the same tumor cell. The company is applying the BiTAC concept to both antibody-drug conjugates (“ADCs”) and T-cell engagers (“TCEs”), with an emphasis on solid tumors. With ADCs and bispecific antibodies attracting substantial investment, VERAXA is operating in oncology markets where technological differentiation can have significant strategic value. VERAXA Biotech (NASDAQ: VRXA) is developing a new generation of antibody-based cancer therapies at a…

TuesdaySep 15, 2026 9:00 am

QualityStocksNewsBreaks – Roth Canada Appoints Mark Hoogeveen to Lead Debt Capital Markets

Roth Canada, the Canadian affiliate of ROTH Capital Partners LLC, announced that Mark Hoogeveen has joined the firm as managing director, head of debt capital markets, where he will lead development of the firm’s debt capital markets offering from its Toronto offices and work closely with ROTH’s U.S.-based investment banking team to provide debt solutions to clients. Hoogeveen brings roughly 30 years of Canadian capital markets experience across equity and debt and most recently served as managing director and co-head of debt capital markets at ATB Cormark Capital Markets after joining Cormark Securities in early 2025 to launch its debt…

MondaySep 14, 2026 2:20 pm

QualityStocksNewsBreaks – Med-X Inc. (Reserved NASDAQ: MXRX) Advances Nature-Cide Natural Pest-Control Platform Ahead of Planned Public-Market Debut

Med-X (Reserved NASDAQ: MXRX), a privately held health and wellness company preparing for a planned Nasdaq listing, is advancing its Nature-Cide brand as the primary growth platform within its portfolio. Nature-Cide develops and commercializes natural pesticide and pest-management products for professional operators and consumers, with applications spanning residential pest control, agriculture, commercial facilities, municipalities and other markets. Med-X also owns Thermal-Aid, a line of reusable heating and cooling pain-relief products, and Malibu Brands, which focuses on essential oil-based wellness solutions. Nature-Cide has expanded from its origins in localized pest-management applications into a portfolio of indoor, outdoor, dust and granular products, with Med-X emphasizing formulation…

MondaySep 14, 2026 1:19 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in NetworkNewsAudio APR Highlighting FDA Clearance of Lucid-MS IND

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) was featured in a NetworkNewsAudio Audio Press Release titled “A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach,” highlighting FDA clearance of the company’s Investigational New Drug (“IND”) application for Lucid-MS. According to the company, the approximately 15,000-page IND submission included a comprehensive package of pharmacology, toxicology and manufacturing data, with the clearance allowing Quantum BioPharma to move directly into a randomized, double-blind, placebo-controlled Phase 2 trial evaluating Lucid-MS in people with multiple sclerosis. Lucid-MS is the company’s patented…

Site Search

Company Search